TCBPW Market Cap from 2010 to 2025

TCBPW Stock  USD 0.01  0  25.19%   
TC BioPharm Market Cap yearly trend continues to be fairly stable with very little volatility. Market Cap will likely drop to about 53.8 B in 2025. During the period from 2010 to 2025, TC BioPharm Market Cap regression line of quarterly data had mean square error of 583313889919.8 T and geometric mean of  1,096,452,963,685. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
56.7 B
Current Value
53.8 B
Quarterly Volatility
1.2 T
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TC BioPharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TC BioPharm's main balance sheet or income statement drivers, such as Interest Income of 1.9 K, Depreciation And Amortization of 638 K or Interest Expense of 90.7 K, as well as many indicators such as Price To Sales Ratio of 199, Dividend Yield of 0.0 or PTB Ratio of 86.71. TCBPW financial statements analysis is a perfect complement when working with TC BioPharm Valuation or Volatility modules.
  
Check out the analysis of TC BioPharm Correlation against competitors.

Latest TC BioPharm's Market Cap Growth Pattern

Below is the plot of the Market Cap of TC BioPharm plc over the last few years. It is TC BioPharm's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TC BioPharm's overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
2.8T2.0T140.049.3B56.7B53.8B-30%-93%-65%15%-5%100%
       Timeline  

TCBPW Market Cap Regression Statistics

Arithmetic Mean2,109,415,003,662
Geometric Mean1,096,452,963,685
Coefficient Of Variation58.50
Mean Deviation1,036,197,261,505
Median2,870,678,852,049
Standard Deviation1,233,922,166,485
Sample Variance1522563912942.5T
Range2.8T
R-Value(0.80)
Mean Square Error583313889919.8T
R-Squared0.64
Significance0.0002
Slope(207,733,314,862)
Total Sum of Squares22838458694137.9T

TCBPW Market Cap History

202553.8 B
202456.7 B
202349.3 B
2022140 B
2021T
20202.8 T

About TC BioPharm Financial Statements

TC BioPharm investors use historical fundamental indicators, such as TC BioPharm's Market Cap, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TC BioPharm. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Market Cap56.7 B53.8 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TCBPW Stock Analysis

When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…